Article Text

Download PDFPDF
Etanercept for plaque psoriasis

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

One in three adults with psoriasis report that it began before they were 16-years-old, usually as plaque psoriasis. The tumour necrosis factor (TNF) receptor fusion protein, etanercept, is a TNF antagonist shown to be effective treatment for adults with psoriasis. Now a trial in North America (Amy S Paller and colleagues. New England Journal of Medicine 2008; …

View Full Text